| scholarly article | Q13442814 |
| P50 | author | John M Dye | Q62478445 |
| Coleen K. Cunningham | Q113482662 | ||
| P2093 | author name string | David A Wohl | |
| William A Fischer | |||
| David A Norwood | |||
| Nathan M Thielman | |||
| David L Hoover | |||
| Samantha E Zak | |||
| Sam Tozay | |||
| James van Hasselt | |||
| Gertrude Jeh-Mulbah | |||
| Jerry F Brown | |||
| Kathleen Rowe | |||
| Peter Zacharias | |||
| P2860 | cites work | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis | Q27001157 |
| Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? | Q28260848 | ||
| Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea | Q28550455 | ||
| Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial | Q28551448 | ||
| Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. | Q30398715 | ||
| Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee | Q34492427 | ||
| A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection | Q34542427 | ||
| Clinical illness and outcomes in patients with Ebola in Sierra Leone | Q35053891 | ||
| Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. | Q35882397 | ||
| The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014 | Q36250219 | ||
| Ebola viral load at diagnosis associates with patient outcome and outbreak evolution | Q36335863 | ||
| Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site | Q36913606 | ||
| Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome | Q37093682 | ||
| Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea | Q39550507 | ||
| Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome | Q39579079 | ||
| Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates | Q40091054 | ||
| Apheresis for collection of Ebola convalescent plasma in Liberia. | Q40097718 | ||
| Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. | Q40132994 | ||
| Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. | Q40254663 | ||
| Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates | Q40433072 | ||
| Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients | Q44089836 | ||
| Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies | Q44104048 | ||
| Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute | Q67317580 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Orthoebolavirus zairense | Q10538943 |
| viral load | Q2528140 | ||
| convalescent plasma | Q105209484 | ||
| P304 | page(s) | 555-562 | |
| P577 | publication date | 2018-07-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease | |
| P478 | volume | 218 |
| Q93150027 | Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 |
| Q91919331 | Convalescent plasma therapy for persistent hepatitis E virus infection |
| Q96769344 | Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods |
| Q97561560 | Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro |
| Q95269001 | Use of convalescent plasma in COVID-19 patients in China |
Search more.